The global in-vitro toxicology testing market size is anticipated to reach USD 30.9 billion by 2027 and is projected to register a CAGR of 9.2% over the forecast period, according to a new report by Grand View Research, Inc. The new paradigm shift in toxicity testing of animal models toward computational methods such as silico models to interpret toxicity pathway data, drives the demand for in-vitro toxicology testing. These methods provide cost and time efficiency and enhance safety assessment.
Several
governments are taking measures to minimize animal-based test models, forming
conducive government policies, and providing funds to support in-vitro models.
These factors are expected to create ample growth opportunities for the market.
For instance, in November 2019, the U.S. National Institute for Environmental
Health Sciences planned to provide funds to small companies for the development
of engineered 3D culture or organotypic culture models (OCM) in-vitro systems.
With
advancements in high throughput screening, biological screening, and chemical
synthesis, the number of publicly available databases containing data related
to toxicity; absorption, distribution, metabolism, and excretion (ADME);
pharmacovigilance; and drug screening has expanded rapidly. This has enabled
scientists to access vast information for toxicity profiling, thereby spurring
revenue generation in this market.
Full Research Report On In-vitro Toxicology Testing Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/in-vitro-toxicology-testing-market
Further key
findings from the report suggest:
- Growing
application of 3D-spheroid-cultures, particularly for nanoparticle toxicity
testing, resulted in the dominance of the cell culture technology segment
in 2019
- Omics
technology is anticipated to register lucrative growth as RNA sequencing
and shotgun proteomics are increasingly used for a more comprehensive
understanding of the effects of toxicants
- The high
usage rate of cellular assays with advancements in cell-based
technologies, including label-free detection and high-content screening,
has contributed to the dominance of the cellular assays segment in 2019
- Systemic
toxicology emerged as the leading application segment in 2019 as it plays
a key role in risk assessment during drug development procedures. For
instance, toxicity testing of systemic immunosuppressive drugs and
systemic corticosteroids is important during the development of drugs for ocular
inflammatory disease
- Pharmaceutical
industry dominated the in-vitro toxicology testing market in 2019 as
toxicological testing is a prerequisite step for drug development
- Stringent
government regulations regarding animal usage for toxicity analysis in
North America have led to an increased adoption rate of in-vitro models.
Hence, North America dominated the global market in 2019
- The Asia
Pacific region is anticipated to witness the fastest growth rate over the
forecast period due to increasing initiatives by public agencies to
encourage acceptance of non-animal test models
- Abbott,
Thermo Fisher, Agilent Technologies, GE Healthcare, Bio-Rad, and Merck
KGaA are some of the key players operating in the market.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/in-vitro-toxicology-testing-market/request/rs1
Grand View Research has
segmented the global in-vitro toxicology testing market on the basis of
technology, method, application, end use, and region:
In-vitro
Toxicology Testing Technology Outlook (Revenue, USD Million, 2016 - 2027)
- Cell Culture Technology
- High Throughput Technology
- Molecular Imaging
- OMICS Technology
In-vitro
Toxicology Testing Method Outlook (Revenue, USD Million, 2016 - 2027)
- Cellular Assay
- Biochemical Assay
- In Silico
- Ex-vivo
In-vitro
Toxicology Testing Application Outlook (Revenue, USD Million, 2016 - 2027)
- Systemic Toxicology
- Dermal Toxicity
- Endocrine Disruption
- Ocular Toxicity
- Others
In-vitro
Toxicology Testing End-use Outlook (Revenue, USD Million, 2016 - 2027)
- Pharmaceutical Industry
- Cosmetics & Household Products
- Diagnostics
- Chemical Industry
- Food Industry
In-vitro
Toxicology Testing Regional Outlook (Revenue, USD Million, 2016 - 2027)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia Pacific
- China
- Japan
- Latin America
- Brazil
- Middle East and Africa (MEA)
- South Africa
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment